Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:29342159

Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.

Precious Takondwa Makondi · Chia-Hwa Lee · Chien-Yu Huang · Chi-Ming Chu · Yu-Jia Chang · Po-Li Wei

PloS one · 2018 doi:10.1371/journal.pone.0189582

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:29342159
kind
science-record
content_hash
sha256:d979748b511334c67856e5b03c7901a872204c2073b37403fe8f2b916bc05c14
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:31Z
updated_at
2026-11-01T21:59:40Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
doi
10.1371/journal.pone.0189582
pmid
29342159
authors array · 6 items
[0]
Precious Takondwa Makondi
[1]
Chia-Hwa Lee
[2]
Chien-Yu Huang
[3]
Chi-Ming Chu
[4]
Yu-Jia Chang
[5]
Po-Li Wei
journal
PloS one
year
2018
abstract
Bevacizumab combined with cytotoxic chemotherapy is the backbone of metastatic colorectal cancer (mCRC) therapy; however, its treatment efficacy is hampered by therapeutic resistance. Therefore, understanding the mechanisms underlying bevacizumab resistance is crucial to increasing the therapeutic efficacy of bevacizumab. The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC. The GEO2R web tool was used to identify differentially expressed genes (DEGs). Functional and pathway enrichment analyses of the DEGs were performed using the Database for Annotation, Visualization, and Integrated Discovery(DAVID). Protein-protein interaction (PPI) networks were established using the Search Tool for the Retrieval of Interacting Genes/Proteins database(STRING) and visualized using Cytoscape software. A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated. PPI network analysis showed that seven upregulated genes and nine downregulated genes exhibited high PPI degrees. In the functional enrichment, the DEGs were mainly enriched in negative regulation of phosphate metabolic process and positive regulation of cell cycle process gene ontologies (GOs); the enriched pathways were the phosphoinositide 3-kinase-serine/threonine kinase signaling pathway, bladder cancer, and microRNAs in cancer. Cyclin-dependent kinase inhibitor 1A(CDKN1A), toll-like receptor 4 (TLR4), CD19 molecule (CD19), breast cancer 1, early onset (BRCA1), platelet-derived growth factor subunit A (PDGFA), and matrix metallopeptidase 1 (MMP1) were the DEGs involved in the pathways and the PPIs. The clinical validation of the DEGs in mCRC (TNM clinical stages 3 and 4) revealed that high PDGFA expression levels were associated with poor overall survival, whereas high BRCA1 and MMP1 expression levels were associated with favorable progress free survival(PFS). The identified genes and pathways can be potential targets and predictors of therapeutic resistance and prognosis in bevacizumab-treated patients with mCRC.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22].
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29342159
locator
sections[3] "Microarray data" paragraph 2
quote
The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22].
state
complete
[1] object · 6 fields
id
claim-data-access
statement
All relevant data are within the paper and its Supporting Information files.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29342159
locator
sections[18] "Data Availability" paragraph 2
quote
All relevant data are within the paper and its Supporting Information files.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
Using the GEO dataset GSE86525 and the GEO2R web tool, the study identified 124 DEGs associated with bevacizumab resistance, including 57 upregulated and 67 downregulated genes.
kind
qualitative
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:29342159
locator
sections[0] "Abstract" paragraph 1
quote
The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC.
[1] object · 3 fields
asset
source:pmid:29342159
locator
sections[0] "Abstract" paragraph 1
quote
The GEO2R web tool was used to identify differentially expressed genes (DEGs).
[2] object · 3 fields
asset
source:pmid:29342159
locator
sections[0] "Abstract" paragraph 1
quote
A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
Using the GEO dataset GSE86525 and the GEO2R web tool, the study identified 124 DEGs associated with bevacizumab resistance, including 57 upregulated and 67 downregulated genes.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:29342159
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE86525
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE86525
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:29342159
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1371/journal.pone.0189582
sha256
sha256:c08bdb989bfefa2beb23a59f3b416e7133dbd2ce39741234abee0c1089c9a31b
bytes
50027
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1371/journal.pone.0189582
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5771567
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE86525
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86525
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE86525
version
null
note
All relevant data are within the paper and its Supporting Information files.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All relevant data are within the paper and its Supporting Information files.
access_statement_kind
data_availability_statement
sample_accessions array · 6 items
[0]
GSM2304992
[1]
GSM2304993
[2]
GSM2304994
[3]
GSM2304995
[4]
GSM2304996
[5]
GSM2304997
sample_count
6
group_sizes
null
group_sizes_basis
null
platform
16699
taxon
Homo sapiens
title
Bevacizumab-resistant HT-29 tumors vs untreated control
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:29342159:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:9c2bb490196b3131a59874f3a95ee1d9319a7ee075bddc73ca0c26eba4f7ec67
bytes
761
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#pone.0189582.t001
version
null
note
Up-regulated genes which had interactions in the PPIs.
structure object · 5 fields
pmcid
PMC5771567
section_index
11
section_title
PPI network analysis
row_count
8
column_count
4
table object · 8 fields
label
Table 1
caption
Up-regulated genes which had interactions in the PPIs.
rows array · 8 items
[0] array · 4 items
[0]
Gene symbol
[1]
Gene name
[2]
Degree
[3]
Betweenness
[1] array · 4 items
[0]
CDKN1A
[1]
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
[2]
38.0
[3]
209.46272
[2] array · 4 items
[0]
MMP1
[1]
matrix metallopeptidase 1 (interstitial collagenase)
[2]
10.0
[3]
20.48990
[3] array · 4 items
[0]
PBX1
[1]
pre-B-cell leukemia homeobox 1
[2]
5.0
[3]
192.13673
[4] array · 4 items
[0]
KIRREL
[1]
kin of IRRE like (Drosophila)
[2]
4.0
[3]
46.28517
[5] array · 4 items
[0]
IGFBP7
[1]
insulin-like growth factor binding protein 7
[2]
4.0
[3]
0.44311
[6] array · 4 items
[0]
DUSP5
[1]
dual specificity phosphatase 5
[2]
3.0
[3]
0.44311
[7] array · 4 items
[0]
PDGFA
[1]
platelet-derived growth factor alpha polypeptide
[2]
2.0
[3]
2.66667
locator
section[11]/table-wrap[1]#pone.0189582.t001
[3] object · 16 fields
id
asset:table:pmid:29342159:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:f4efe3fcb16e6fd1c4c39abee79b7178b8d6669a0dd0b4b8ba0d79eec54fa9c4
bytes
742
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[2]#pone.0189582.t002
version
null
note
Down-regulated genes which had interactions in the PPIs.
structure object · 5 fields
pmcid
PMC5771567
section_index
11
section_title
PPI network analysis
row_count
10
column_count
4
table object · 8 fields
label
Table 2
caption
Down-regulated genes which had interactions in the PPIs.
rows array · 10 items
[0] array · 4 items
[0]
Gene symbol
[1]
Gene name
[2]
Degree
[3]
Betweenness
[1] array · 4 items
[0]
BRCA1
[1]
breast cancer 1, early onset
[2]
35.0
[3]
326.96054
[2] array · 4 items
[0]
FANCD2
[1]
fanconi anemia complementation group D2
[2]
19.0
[3]
33.54729
[3] array · 4 items
[0]
RBL1
[1]
retinoblastoma-like 1 (p107)
[2]
13.0
[3]
12.75956
[4] array · 4 items
[0]
TLR4
[1]
toll-like receptor 4
[2]
8.0
[3]
31.75171
[5] array · 4 items
[0]
GINS4
[1]
GINS complex subunit 4
[2]
4.0
[3]
0.0
[6] array · 4 items
[0]
CD19
[1]
CD19 molecule
[2]
2.0
[3]
0.0
[7] array · 4 items
[0]
HEATR1
[1]
HEAT repeat containing 1
[2]
2.0
[3]
0.0
[8] array · 4 items
[0]
PSMB11
[1]
proteasome subunit beta 11
[2]
2.0
[3]
0.0
[9] array · 4 items
[0]
BLVRA
[1]
biliverdin reductase A
[2]
2.0
[3]
0.0
locator
section[11]/table-wrap[2]#pone.0189582.t002
[4] object · 16 fields
id
asset:table:pmid:29342159:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4c69da83b94306c0b466cbbb66e5ca1257b7c7482f7826e9af78af4696b54269
bytes
824
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#pone.0189582.t003
version
null
note
Enriched Gene-Ontologies (GO’s).
structure object · 5 fields
pmcid
PMC5771567
section_index
12
section_title
Functional enrichment analysis
row_count
6
column_count
4
table object · 8 fields
label
Table 3
caption
Enriched Gene-Ontologies (GO’s).
rows array · 6 items
[0] array · 4 items
[0]
Gene-Ontology
[1]
Genes
[2]
p-value
[3]
FDRa
[1] array · 4 items
[0]
negative regulation of phosphate metabolic process (GO:0045936)
[1]
DUSP5, CDKN1A, KIRREL, PDGFA, TLR4
[2]
0.00002184
[3]
0.004597
[2] array · 4 items
[0]
positive regulation of cell cycle process (GO:0090068)
[1]
PSMB11, CDKN1A, BRCA1, PBX1
[2]
0.00002337
[3]
0.004597
[3] array · 4 items
[0]
regulation of lipid metabolic process (GO:0019216)
[1]
RBL1, PDGFA, IGFBP7, BRCA1
[2]
0.00003562
[3]
0.004597
[4] array · 4 items
[0]
positive regulation of cell cycle arrest (GO:0071158)
[1]
PSMB11, CDKN1A, BRCA1
[2]
0.00003986
[3]
0.004597
[5] array · 4 items
[0]
DNA damage response, signal transduction by p53 class mediator (GO:0030330)
[1]
PSMB11, CDKN1A, BRCA1
[2]
0.00004889
[3]
0.004597
locator
section[12]/table-wrap[1]#pone.0189582.t003
[5] object · 16 fields
id
asset:table:pmid:29342159:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:da304e86753273b7c989d3a4a2193963af214f212b9869b368d637adadca56ae
bytes
484
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[13]/table-wrap[1]#pone.0189582.t004
version
null
note
Enriched KEGG pathways.
structure object · 5 fields
pmcid
PMC5771567
section_index
13
section_title
KEGG pathway analysis
row_count
4
column_count
4
table object · 8 fields
label
Table 4
caption
Enriched KEGG pathways.
rows array · 4 items
[0] array · 4 items
[0]
KEGGa pathway
[1]
Genes
[2]
p-value
[3]
FDRb
[1] array · 4 items
[0]
PI3K-Akt signaling pathway(hsa04151)
[1]
CDKN1A, CD19, PDGFA, BRCA1, TLR4
[2]
0.000005237
[3]
0.0003037
[2] array · 4 items
[0]
Bladder cancer(hsa05219)
[1]
CDKN1A, MMP1
[2]
0.000483151
[3]
0.009340926
[3] array · 4 items
[0]
MicroRNAs in cancer(hsa05206)
[1]
CDKN1A, PDGFA, BRCA1
[2]
0.001572901
[3]
0.01303
locator
section[13]/table-wrap[1]#pone.0189582.t004
gaps array · 2 items
[0]
asset:data:geo:GSE86525 not downloaded
[1]
asset:data:geo:GSE86525 licence not read
analysis object · 4 fields
state
partial
methods array · 5 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Kaplan-Meier
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[2] object · 10 fields
id
method-3
family
network_analysis
specific
ppi_network
label
Network / pathway analysis
dsl_operations array · 3 items
[0]
build_graph
[1]
centrality_scores
[2]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
Protein-protein interaction
[3] object · 10 fields
id
method-4
family
network_analysis
specific
pathway_enrichment
label
Network / pathway analysis
dsl_operations array · 1 item
[0]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
pathway enrichment
[4] object · 10 fields
id
method-5
family
null
specific
null
label
Fisher exact test, followed by Benjamini and Hochberg false discovery rate correction
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22].
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE86525
resolved_accessions array · 1 item
[0]
GSE86525
statements array · 1 item
[0]
All relevant data are within the paper and its Supporting Information files.
basis
The paper names GSE86525 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
survival_km
assets array · 6 items
[0]
source:pmid:29342159
[1]
data:geo:GSE86525
[2]
asset:table:pmid:29342159:1
[3]
asset:table:pmid:29342159:2
[4]
asset:table:pmid:29342159:3
[5]
asset:table:pmid:29342159:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE86525
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:33:22Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
113662
completion_tokens
3691
cached_tokens
2104
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:29342159
type
paper
label
pmid:29342159
[1] object · 3 fields
id
source:pmid:29342159
type
manuscript
label
PMID 29342159 full text
[2] object · 3 fields
id
data:geo:GSE86525
type
dataset
label
GEO GSE86525
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:29342159
type
paper
label
pmid:29342159
[1] object · 3 fields
id
source:pmid:29342159
type
manuscript
label
PMID 29342159 full text
[2] object · 3 fields
id
data:geo:GSE86525
type
dataset
label
GEO GSE86525
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-29342159
type
extraction
used array · 1 item
[0]
source:pmid:29342159
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE86525
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE86525
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:29342159
parent_hash
sha256:238536a64bd116ca07a5dec7f8284b0c2c3b67932b8a1874cc5b559059fbc320
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:GSE86525 licence not read
[1]
asset:data:geo:GSE86525 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
survival_km
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Kaplan-Meier
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:29342159", "kind": "science-record", "revision": 7, "content_hash": "sha256:d979748b511334c67856e5b03c7901a872204c2073b37403fe8f2b916bc05c14", "created_at": "2026-11-01T15:40:31Z", "updated_at": "2026-11-01T21:59:40Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.", "doi": "10.1371/journal.pone.0189582", "pmid": "29342159", "authors": ["Precious Takondwa Makondi", "Chia-Hwa Lee", "Chien-Yu Huang", "Chi-Ming Chu", "Yu-Jia Chang", "Po-Li Wei"], "journal": "PloS one", "year": 2018, "abstract": "Bevacizumab combined with cytotoxic chemotherapy is the backbone of metastatic colorectal cancer (mCRC) therapy; however, its treatment efficacy is hampered by therapeutic resistance. Therefore, understanding the mechanisms underlying bevacizumab resistance is crucial to increasing the therapeutic efficacy of bevacizumab. The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC. The GEO2R web tool was used to identify differentially expressed genes (DEGs). Functional and pathway enrichment analyses of the DEGs were performed using the Database for Annotation, Visualization, and Integrated Discovery(DAVID). Protein-protein interaction (PPI) networks were established using the Search Tool for the Retrieval of Interacting Genes/Proteins database(STRING) and visualized using Cytoscape software. A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated. PPI network analysis showed that seven upregulated genes and nine downregulated genes exhibited high PPI degrees. In the functional enrichment, the DEGs were mainly enriched in negative regulation of phosphate metabolic process and positive regulation of cell cycle process gene ontologies (GOs); the enriched pathways were the phosphoinositide 3-kinase-serine/threonine kinase signaling pathway, bladder cancer, and microRNAs in cancer. Cyclin-dependent kinase inhibitor 1A(CDKN1A), toll-like receptor 4 (TLR4), CD19 molecule (CD19), breast cancer 1, early onset (BRCA1), platelet-derived growth factor subunit A (PDGFA), and matrix metallopeptidase 1 (MMP1) were the DEGs involved in the pathways and the PPIs. The clinical validation of the DEGs in mCRC (TNM clinical stages 3 and 4) revealed that high PDGFA expression levels were associated with poor overall survival, whereas high BRCA1 and MMP1 expression levels were associated with favorable progress free survival(PFS). The identified genes and pathways can be potential targets and predictors of therapeutic resistance and prognosis in bevacizumab-treated patients with mCRC.", "claims": [{"id": "claim-method", "statement": "The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22].", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29342159", "locator": "sections[3] \"Microarray data\" paragraph 2", "quote": "The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22]."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All relevant data are within the paper and its Supporting Information files.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29342159", "locator": "sections[18] \"Data Availability\" paragraph 2", "quote": "All relevant data are within the paper and its Supporting Information files."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Using the GEO dataset GSE86525 and the GEO2R web tool, the study identified 124 DEGs associated with bevacizumab resistance, including 57 upregulated and 67 downregulated genes.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:29342159", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC."}, {"asset": "source:pmid:29342159", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "The GEO2R web tool was used to identify differentially expressed genes (DEGs)."}, {"asset": "source:pmid:29342159", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Using the GEO dataset GSE86525 and the GEO2R web tool, the study identified 124 DEGs associated with bevacizumab resistance, including 57 upregulated and 67 downregulated genes.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:29342159"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE86525"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE86525"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:29342159", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1371/journal.pone.0189582", "sha256": "sha256:c08bdb989bfefa2beb23a59f3b416e7133dbd2ce39741234abee0c1089c9a31b", "bytes": 50027, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1371/journal.pone.0189582", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5771567", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE86525", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86525", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE86525", "version": null, "note": "All relevant data are within the paper and its Supporting Information files.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All relevant data are within the paper and its Supporting Information files.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2304992", "GSM2304993", "GSM2304994", "GSM2304995", "GSM2304996", "GSM2304997"], "sample_count": 6, "group_sizes": null, "group_sizes_basis": null, "platform": "16699", "taxon": "Homo sapiens", "title": "Bevacizumab-resistant HT-29 tumors vs untreated control", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:29342159:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:9c2bb490196b3131a59874f3a95ee1d9319a7ee075bddc73ca0c26eba4f7ec67", "bytes": 761, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#pone.0189582.t001", "version": null, "note": "Up-regulated genes which had interactions in the PPIs.", "structure": {"pmcid": "PMC5771567", "section_index": 11, "section_title": "PPI network analysis", "row_count": 8, "column_count": 4}, "table": {"label": "Table 1", "caption": "Up-regulated genes which had interactions in the PPIs.", "rows": [["Gene symbol", "Gene name", "Degree", "Betweenness"], ["CDKN1A", "cyclin-dependent kinase inhibitor 1A (p21, Cip1)", "38.0", "209.46272"], ["MMP1", "matrix metallopeptidase 1 (interstitial collagenase)", "10.0", "20.48990"], ["PBX1", "pre-B-cell leukemia homeobox 1", "5.0", "192.13673"], ["KIRREL", "kin of IRRE like (Drosophila)", "4.0", "46.28517"], ["IGFBP7", "insulin-like growth factor binding protein 7", "4.0", "0.44311"], ["DUSP5", "dual specificity phosphatase 5", "3.0", "0.44311"], ["PDGFA", "platelet-derived growth factor alpha polypeptide", "2.0", "2.66667"]], "row_count": 8, "column_count": 4, "numeric_cells": 19, "header_rows": 1, "locator": "section[11]/table-wrap[1]#pone.0189582.t001"}}, {"id": "asset:table:pmid:29342159:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f4efe3fcb16e6fd1c4c39abee79b7178b8d6669a0dd0b4b8ba0d79eec54fa9c4", "bytes": 742, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#pone.0189582.t002", "version": null, "note": "Down-regulated genes which had interactions in the PPIs.", "structure": {"pmcid": "PMC5771567", "section_index": 11, "section_title": "PPI network analysis", "row_count": 10, "column_count": 4}, "table": {"label": "Table 2", "caption": "Down-regulated genes which had interactions in the PPIs.", "rows": [["Gene symbol", "Gene name", "Degree", "Betweenness"], ["BRCA1", "breast cancer 1, early onset", "35.0", "326.96054"], ["FANCD2", "fanconi anemia complementation group D2", "19.0", "33.54729"], ["RBL1", "retinoblastoma-like 1 (p107)", "13.0", "12.75956"], ["TLR4", "toll-like receptor 4", "8.0", "31.75171"], ["GINS4", "GINS complex subunit 4", "4.0", "0.0"], ["CD19", "CD19 molecule", "2.0", "0.0"], ["HEATR1", "HEAT repeat containing 1", "2.0", "0.0"], ["PSMB11", "proteasome subunit beta 11", "2.0", "0.0"], ["BLVRA", "biliverdin reductase A", "2.0", "0.0"]], "row_count": 10, "column_count": 4, "numeric_cells": 27, "header_rows": 1, "locator": "section[11]/table-wrap[2]#pone.0189582.t002"}}, {"id": "asset:table:pmid:29342159:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4c69da83b94306c0b466cbbb66e5ca1257b7c7482f7826e9af78af4696b54269", "bytes": 824, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#pone.0189582.t003", "version": null, "note": "Enriched Gene-Ontologies (GO’s).", "structure": {"pmcid": "PMC5771567", "section_index": 12, "section_title": "Functional enrichment analysis", "row_count": 6, "column_count": 4}, "table": {"label": "Table 3", "caption": "Enriched Gene-Ontologies (GO’s).", "rows": [["Gene-Ontology", "Genes", "p-value", "FDRa"], ["negative regulation of phosphate metabolic process (GO:0045936)", "DUSP5, CDKN1A, KIRREL, PDGFA, TLR4", "0.00002184", "0.004597"], ["positive regulation of cell cycle process (GO:0090068)", "PSMB11, CDKN1A, BRCA1, PBX1", "0.00002337", "0.004597"], ["regulation of lipid metabolic process (GO:0019216)", "RBL1, PDGFA, IGFBP7, BRCA1", "0.00003562", "0.004597"], ["positive regulation of cell cycle arrest (GO:0071158)", "PSMB11, CDKN1A, BRCA1", "0.00003986", "0.004597"], ["DNA damage response, signal transduction by p53 class mediator (GO:0030330)", "PSMB11, CDKN1A, BRCA1", "0.00004889", "0.004597"]], "row_count": 6, "column_count": 4, "numeric_cells": 18, "header_rows": 1, "locator": "section[12]/table-wrap[1]#pone.0189582.t003"}}, {"id": "asset:table:pmid:29342159:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:da304e86753273b7c989d3a4a2193963af214f212b9869b368d637adadca56ae", "bytes": 484, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[13]/table-wrap[1]#pone.0189582.t004", "version": null, "note": "Enriched KEGG pathways.", "structure": {"pmcid": "PMC5771567", "section_index": 13, "section_title": "KEGG pathway analysis", "row_count": 4, "column_count": 4}, "table": {"label": "Table 4", "caption": "Enriched KEGG pathways.", "rows": [["KEGGa pathway", "Genes", "p-value", "FDRb"], ["PI3K-Akt signaling pathway(hsa04151)", "CDKN1A, CD19, PDGFA, BRCA1, TLR4", "0.000005237", "0.0003037"], ["Bladder cancer(hsa05219)", "CDKN1A, MMP1", "0.000483151", "0.009340926"], ["MicroRNAs in cancer(hsa05206)", "CDKN1A, PDGFA, BRCA1", "0.001572901", "0.01303"]], "row_count": 4, "column_count": 4, "numeric_cells": 10, "header_rows": 1, "locator": "section[13]/table-wrap[1]#pone.0189582.t004"}}], "gaps": ["asset:data:geo:GSE86525 not downloaded", "asset:data:geo:GSE86525 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-2", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-3", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "Protein-protein interaction"}}, {"id": "method-4", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "pathway enrichment"}}, {"id": "method-5", "family": null, "specific": null, "label": "Fisher exact test, followed by Benjamini and Hochberg false discovery rate correction", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The expression data were further analyzed using GeneSpring GX software (version 11.0, Agilent Technologies), and the differentially expressed genes (DEGs) between the bevacizumab-resistant HT29 tumors vs untreated control were compared using the Fisher exact test, followed by multiple corrections using the Benjamini and Hochberg false discovery rate (FDR) method [22]."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE86525"], "resolved_accessions": ["GSE86525"], "statements": ["All relevant data are within the paper and its Supporting Information files."], "basis": "The paper names GSE86525 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:29342159", "data:geo:GSE86525", "asset:table:pmid:29342159:1", "asset:table:pmid:29342159:2", "asset:table:pmid:29342159:3", "asset:table:pmid:29342159:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE86525"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:33:22Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 113662, "completion_tokens": 3691, "cached_tokens": 2104}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:29342159", "type": "paper", "label": "pmid:29342159"}, {"id": "source:pmid:29342159", "type": "manuscript", "label": "PMID 29342159 full text"}, {"id": "data:geo:GSE86525", "type": "dataset", "label": "GEO GSE86525"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:29342159", "type": "paper", "label": "pmid:29342159"}, {"id": "source:pmid:29342159", "type": "manuscript", "label": "PMID 29342159 full text"}, {"id": "data:geo:GSE86525", "type": "dataset", "label": "GEO GSE86525"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-29342159", "type": "extraction", "used": ["source:pmid:29342159"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE86525", "type": "accession_resolution", "used": ["data:geo:GSE86525"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:29342159", "parent_hash": "sha256:238536a64bd116ca07a5dec7f8284b0c2c3b67932b8a1874cc5b559059fbc320", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:GSE86525 licence not read", "asset:data:geo:GSE86525 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Kaplan-Meier"], "order_basis": "analysis_only", "id": "assay:1"}]}